APA

Klil-Drori A. J., Yin H., Azoulay L., Harnois M., Gratton M., Del Corpo A., Olney H. J., Delage R., Laneuville P., Mollica L., Busque L. & Assouline S. E. (20171130). Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response. : American journal of hematology.

Chicago

Klil-Drori Adi J, Yin Hui, Azoulay Laurent, Harnois Michaël, Gratton Michel-Olivier, Del Corpo Alexa, Olney Harold J, Delage Robert, Laneuville Pierre, Mollica Luigina, Busque Lambert and Assouline Sarit E. 20171130. Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response. : American journal of hematology.

Harvard

Klil-Drori A. J., Yin H., Azoulay L., Harnois M., Gratton M., Del Corpo A., Olney H. J., Delage R., Laneuville P., Mollica L., Busque L. and Assouline S. E. (20171130). Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response. : American journal of hematology.

MLA

Klil-Drori Adi J, Yin Hui, Azoulay Laurent, Harnois Michaël, Gratton Michel-Olivier, Del Corpo Alexa, Olney Harold J, Delage Robert, Laneuville Pierre, Mollica Luigina, Busque Lambert and Assouline Sarit E. Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response. : American journal of hematology. 20171130.